Medical Research - Dr. Jesse Stoff MD
Dr. Jesse A. Stoff, MD has devoted much of the later part of his career in medicine to research aimed at improving the lives of others. His outstanding performance and ethics has led to many findings and a plethora of research materials used and referenced by students, professors, and medical practitioners alike.
A. Chief Science Officer Immune Biologics (Scottsdale, AZ 2001-current), Formally incorporated as: Quantum Research
B. Patents filed in 7 different classes for:
Producing, processing and assaying BLC, under the heading of: IMMUNODYNAMIC COMPLEXES AND METHODS FOR USING AND PREPARING SUCH COMPLEXES
C. Manuscript Title: A Pilot Study of an anti-MRSA Bio-Engineered Lacteal Complex
(anti-MRSA BLC) in a Murine Septicemia Model Vol 28 No 4/Oct-Dec 2006 By: Stoff; Nix; DeYoung
D. Developed a number of successful protocols for the therapeutic application of targeted HUCB stem cells for people with cancer, auto-immune diseases, multiple sclerosis and ALS.
E. Discovered Bio-Engineered Lacteal Complex (BLC), a pathogen specific biological complex with 5 mechanisms of action that represents a new class of biologic antibiotics and includes a provision for the treatment of cancer.
Dr. Jesse A. Stoff, MD has devoted much of the later part of his career in medicine to research aimed at improving the lives of others. His outstanding performance and ethics has led to many findings and a plethora of research materials used and referenced by students, professors, and medical practitioners alike.
A. Chief Science Officer Immune Biologics (Scottsdale, AZ 2001-current), Formally incorporated as: Quantum Research
B. Patents filed in 7 different classes for:
Producing, processing and assaying BLC, under the heading of: IMMUNODYNAMIC COMPLEXES AND METHODS FOR USING AND PREPARING SUCH COMPLEXES
C. Manuscript Title: A Pilot Study of an anti-MRSA Bio-Engineered Lacteal Complex
(anti-MRSA BLC) in a Murine Septicemia Model Vol 28 No 4/Oct-Dec 2006 By: Stoff; Nix; DeYoung
D. Developed a number of successful protocols for the therapeutic application of targeted HUCB stem cells for people with cancer, auto-immune diseases, multiple sclerosis and ALS.
E. Discovered Bio-Engineered Lacteal Complex (BLC), a pathogen specific biological complex with 5 mechanisms of action that represents a new class of biologic antibiotics and includes a provision for the treatment of cancer.